Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYPERS: Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease
NCT05583721Phase 2Recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Oct 2023
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 2, open-label trial (3 arms), sponsored by St. Jude Children's Research Hospital. Primary endpoints: Coronary Flow Reserve at 4 weeks and Coronary Flow Reserve difference at 4 weeks. Started Oct 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05583721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05583721.